Dear Shareholders

2023 was considered as the year where the COVID-19 outbreak situation continuously improved and recovered to normal condition. However, there are clusters of outbreaks continued after the holiday season with disease severity significantly decreased, while the seasonal outbreaks were increased throughout the June - October period of 2023. At the same time, Medical Tourism and international patients, especially from Cambodia, Lao PDR, Myanmar, and Vietnam (CLMV) traveled to get treatment in affiliated hospitals are increasing significantly as a result from the opening borders.

The Company and its affiliated hospitals are committed to continuously improving the quality and standards of service through the addition of specialized medical centers, i.e. the Magnetic Resonance Imaging Center (MRI), Health and Occupational Medicine Examination Center, Gastrointestinal and Liver Center, and Cosmetic Surgery Center.

Prof. Dr. Chalerm Harnphanich, M.D.

Chief Executive Officer

As well as expanding the network of Kasemrad Medical and Dental Clinic Saraburi, Hin Kong Subdistrict, Nong Khae District, to improve the quality of life for people in the vicinity and receive referrals to Kasemrad Hospital Saraburi along with improving the service areas for inpatient and outpatient with long time service in the same hospitals, i.e. Kasemrad Hospital Prachachuen, Kasemrad Hospital Saraburi, and Kasemrad Hospital Chachoengsao, as well as upgrading service technology in affiliated hospitals to support the increasing demand for medical services and preventive health care.

For performance in 2023, the Company had total income of 11,829.9 million baht, a decrease of (37.4) percent, however, an increase of 31.6 percent compared to 2019 from the growth of the new hospitals' revenue base, including Kasemrad International Hospital Aranyaprathet, Kasemrad International Hospital Vientiane, and Kasemrad Hospital, Prachinburi, the return for medical of Thai patients and international patients in specialized medical centers, and a significant increase in seasonal epidemics. The Company reported a net profit attributable to the Company of 1,406.4 million baht, a decrease of (53.7) percent compared to the previous year and increased by 23.9 percent compared to 2019 before the COVID-19 outbreak.

Throughout the past, the Company be aware of the importance of employees at all levels. Since the employees are the important resources for business operation. In 2023, the Company organized a project to promote innovative creation for operations through the Innovation contest activity as a channel for employees to express their opinions and suggestions, developing and improving operational efficiency, providing training to enhance skills and abilities, along with organizing activities to encourage personnel to feel engaged with the Company's business growth. The Company is also aware of maintaining good relationships with society, communities, and stakeholders outside the organization through organizing joint activities i.e. Health examinations and vaccinations in community areas close to affiliated hospitals, as well as organizing health education activities for patients and the public.

In conclusion, all executives are committed to managing the business to achieve the Company's goals. In addition, the medical personnel and employees of the Company are dedicated with physical and mental strength to work together and push goal to be successful, along with responsibility for the environment, society, and corporate governance. To continue operating the business on a good and sustainable foundation.